Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2253-2256

  Wilkerson, Craig L ^a   Darjatmoko, Soesiawati R ^a   Lindstrom, Mary J ^a   Albert, Daniel M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; GROWTH INHIBITION; HYPERCALCEMIA; NONHUMAN; PRIORITY JOURNAL; RETINOBLASTOMA; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CALCITRIOL; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICE; MICE, NUDE; MICE, TRANSGENIC; RETINOBLASTOMA;

EID: 0031716628     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wardrop, J. Observations on the Fungus Haematodes. Edinburgh: Constable, 1809.
2. Verhoeff, F., and Jackson, E. Minutes of the proceedings: Sixty-second Annual Meeting. Trans. Am. Ophthalmol. Soc., 24: 38, 1926.
3. Knudson, A. G., Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
4. Friend, S., Bernard, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P. A human DNA sequence with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 643-646, 1986.
5. Ferris, F., and Chew, E. A new era for the treatment of retinoblastomas. Arch. Ophthalmol., 114: 1412, 1996.
6. Gallie, B., Budnig, A., DeBoer, G., Thiessen, J. J., Koren, G., Verjee, Z., Ling, V., and Chan, H. S. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch. Ophthalmol., 114: 1321-1328, 1996.
7. Murphree, A., Villablanca, J., Deegan, W., III, Sato, J. K., Malogolowkin, M., Fisher, A., Parker, R., Reed, E., and Gomer, C. J. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch. Ophthalmol., 114: 1348-1356, 1996.
8. Murray, T., O'Brien, J., Steeves, R., Smith, B. J., Albert, D. M., Cicciarelli, N., Markoe, A. M., Tompkins, D. T., and Windle, J. J. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma. Arch. Ophthalmol., 114: 1376-1381, 1996.
9. Verhoeff, F. H. Retinoblastoma undergoing spontaneous regression. Calcifying agent suggested in treatment of retinoblastoma. Am. J. Ophthalmol., 62: 573-574, 1966.
10. Saulenas, A., Cohen, S., Key, L., Winter, C., and Albert, D. Vitamin D and retinoblastoma: the presence of receptors and inhibition of growth in vitro. Arch. Ophthalmol., 106: 533-535, 1988.
11. Cohen, S., Saulenas, A., Sullivan, C. and Albert, D. Further studies of the effect of vitamin D on retinoblastoma inhibition with 1,25 dihydroxycholecalciferol. Arch. Ophthalmol., 106: 541-543, 1988.
12. Albert, D. M., Marcus, D. M., Gallo, J. P., and O'Brien, J. M. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma. Investig. Ophthalmol. Vis. Sci., 33: 2354-2364, 1992.
13. Reichel, H., Koeffler, H., and Norman, A. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med., 320: 980-991, 1989.
14. Bouillon, R., Verstuyf, A., Verlinden, L., Allewaert, K., Branisteanu, D., Mathieu, C., and van Baelen, H. Non-hypercalcemic pharmacological aspects of vitamin D analogs. Biochem. Pharmacol., 50: 277-283, 1995.
15. 3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leuk. Res., 18: 453-463, 1994.
16. 3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4. J. Cancer Res. Clin. Oncol., 118: 190-194, 1992.
17. 3 derivatives and breast tumor cell growth: effect on intracellular calcium and apoptosis. Int. J. Cancer, 61: 806-811, 1995.
18. 3 and prostate cancer cell proliferation in vivo. Urology, 46: 365-369, 1995.
19. 3. Cancer Res., 54: 4057-4064, 1994.
20. Windle, J. J., Albert, D. M., O'Brien, J. M., Marcus, D. M., Disteche, C. M., Bernards, R., and Mellon, P. L. Retinoblastoma in transgenic mice. Nature (Lond.), 343: 665-669, 1990.
21. 3 analog in transgenic mice with retinoblastoma. Arch. Ophthalmol., 114: 1396-1401, 1996.
22. 3 prolongs survival time of leukemic mice. Proc. Natl. Acad. Sci. USA, 87: 3929-3932, 1990.
23. Mortensen, J. T., Brinck, P., and Binderup, L. Toxicity of vitamin D analogues in rats fed diets with standard or low calcium contents. Pharmacol. Toxicol., 72: 124-127, 1993.
24. 3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia). J. Bone Miner. Res., 7: 457-463, 1992.
25. 3 and two analogues. Cancer Res., 53: 3935-3942, 1993.
26. Chambers, J. H. Statistical Models in S. Belmont, CA: Wadsworth, 1992.
27. 3 derivatives on growth, differentiation and apoptosis in tumoral colonie HT 29 cells: possible implication of intracellular calcium. Cancer Lett., 97: 99-106, 1995.
28. 3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk. Res., 19: 65-72, 1995.